Statement of the ESHG on direct-to-consumer genetic testing for health-related purposes.

PubWeight™: 2.65‹?› | Rank: Top 1%

🔗 View Article (PMC 3002858)

Published in Eur J Hum Genet on August 25, 2010

Authors

European Society of Human Genetics

Articles citing this

Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer. Cancer Res (2011) 2.27

Motivations and perceptions of early adopters of personalized genomics: perspectives from research participants. Public Health Genomics (2011) 1.96

Whole-genome sequencing in health care: recommendations of the European Society of Human Genetics. Eur J Hum Genet (2013) 1.93

You never call, you never write: why return of 'omic' results to research participants is both a good idea and a moral imperative. Per Med (2011) 1.75

Legislation on direct-to-consumer genetic testing in seven European countries. Eur J Hum Genet (2012) 1.53

Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents. Am J Hum Genet (2015) 1.50

Direct-to-consumer genomic testing: systematic review of the literature on user perspectives. Eur J Hum Genet (2012) 1.38

Preconceptional genetic carrier testing and the commercial offer directly-to-consumers. Hum Reprod (2011) 1.32

Whole-genome sequencing in health care. Recommendations of the European Society of Human Genetics. Eur J Hum Genet (2013) 1.31

Where are you going, where have you been: a recent history of the direct-to-consumer genetic testing market. J Community Genet (2010) 1.28

Users' motivations to purchase direct-to-consumer genome-wide testing: an exploratory study of personal stories. J Community Genet (2011) 1.28

A tiered-layered-staged model for informed consent in personal genome testing. Eur J Hum Genet (2012) 1.27

Closure of population biobanks and direct-to-consumer genetic testing companies. Hum Genet (2011) 1.26

Is there a doctor in the house? : The presence of physicians in the direct-to-consumer genetic testing context. J Community Genet (2011) 1.25

Blurring lines. The research activities of direct-to-consumer genetic testing companies raise questions about consumers as research subjects. EMBO Rep (2010) 1.15

Genotype prediction of adult type 2 diabetes from adolescence in a multiracial population. Pediatrics (2012) 1.05

Counseling customers: emerging roles for genetic counselors in the direct-to-consumer genetic testing market. J Genet Couns (2012) 1.00

The role of disease characteristics in the ethical debate on personal genome testing. BMC Med Genomics (2012) 0.99

Personal genetics: regulatory framework in Europe from a service provider's perspective. Eur J Hum Genet (2010) 0.98

Are the kids really all right? Direct-to-consumer genetic testing in children: are company policies clashing with professional norms? Eur J Hum Genet (2011) 0.98

Genetic testing legislation in Western Europe-a fluctuating regulatory target. J Community Genet (2012) 0.98

'Someday it will be the norm': physician perspectives on the utility of genome sequencing for patient care in the MedSeq Project. Per Med (2015) 0.93

Survey of European clinical geneticists on awareness, experiences and attitudes towards direct-to-consumer genetic testing. Genome Med (2013) 0.92

The promises of genomic screening: building a governance infrastructure. Special issue: genetics and democracy. J Community Genet (2011) 0.92

Direct-to-consumer genomic testing from the perspective of the health professional: a systematic review of the literature. J Community Genet (2013) 0.90

The challenge of implementing genetic tests with clinical utility while avoiding unsound applications. J Community Genet (2012) 0.89

Current issues in medically assisted reproduction and genetics in Europe: research, clinical practice, ethics, legal issues and policy. European Society of Human Genetics and European Society of Human Reproduction and Embryology. Eur J Hum Genet (2013) 0.87

The impact of risk information exposure on women's beliefs about direct-to-consumer genetic testing for BRCA mutations. Clin Genet (2011) 0.83

Whole-genome sequencing in newborn screening? A statement on the continued importance of targeted approaches in newborn screening programmes. Eur J Hum Genet (2015) 0.83

Expanded carrier screening panels-does bigger mean better? J Community Genet (2013) 0.83

Direct-to-consumer genetic testing in Slovenia: availability, ethical dilemmas and legislation. Biochem Med (Zagreb) (2015) 0.81

Genetic prediction of common diseases. Still no help for the clinical diabetologist! Nutr Metab Cardiovasc Dis (2012) 0.80

Europe and direct-to-consumer genetic tests. Nat Rev Genet (2011) 0.78

Health care providers and direct-to-consumer access and advertising of genetic testing in the United States. Genome Med (2011) 0.78

Cost analysis of whole genome sequencing in German clinical practice. Eur J Health Econ (2016) 0.77

Ethical issues in consumer genome sequencing: Use of consumers' samples and data. Appl Transl Genom (2016) 0.77

The perspective from EASAC and FEAM on direct-to-consumer genetic testing for health-related purposes. Eur J Hum Genet (2012) 0.76

Comparison of commercial genetic-testing services in Korea with 23andMe service. Biomed Res Int (2014) 0.75

Stakeholder perspectives on the implementation of genetic carrier screening in a changing landscape. BMC Health Serv Res (2017) 0.75

Patient knowledge and information-seeking about personalized cancer therapy. Int J Med Inform (2016) 0.75

Impact of direct-to-consumer genetic testing. J Oncol Pract (2012) 0.75

Genomic analysis in the clinic: benefits and challenges for health care professionals and patients in Brazil. J Community Genet (2015) 0.75

The documentation of consent and disclosure of neurogenetic testing outside clinical genetics. Neurogenetics (2014) 0.75

Transparency of genetic testing services for 'health, wellness and lifestyle': analysis of online prepurchase information for UK consumers. Eur J Hum Genet (2017) 0.75

Third party interpretation of raw genetic data: an ethical exploration. Eur J Hum Genet (2017) 0.75

Articles by these authors

Genetic testing in asymptomatic minors: Recommendations of the European Society of Human Genetics. Eur J Hum Genet (2009) 1.80

Recommendations for reporting results of diagnostic genetic testing (biochemical, cytogenetic and molecular genetic). Eur J Hum Genet (2013) 1.46

Guidelines for diagnostic next-generation sequencing. Eur J Hum Genet (2015) 1.42

Data storage and DNA banking for biomedical research: technical, social and ethical issues. Eur J Hum Genet (2003) 1.40

Non-invasive prenatal testing for aneuploidy and beyond: challenges of responsible innovation in prenatal screening. Eur J Hum Genet (2015) 1.21

The need for interaction between assisted reproduction technology and genetics. Recommendations of the European Societies of Human Genetics and Human Reproduction and Embryology. Eur J Hum Genet (2006) 0.87

Population genetic screening programmes: technical, social and ethical issues. Eur J Hum Genet (2003) 0.86

Genetic information and testing in insurance and employment: technical, social and ethical issues. Eur J Hum Genet (2003) 0.86

Whole-genome sequencing in newborn screening? A statement on the continued importance of targeted approaches in newborn screening programmes. Eur J Hum Genet (2015) 0.83

Provision of genetic services in Europe: current practices and issues. Eur J Hum Genet (2003) 0.77

The need for interaction between assisted reproduction technology and genetics: recommendations of the European Societies of Human Genetics and Human Reproduction and Embryology. Hum Reprod (2006) 0.75